Top

Published in:

Open Access 01-12-2023 | Correction

Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy

Authors: Sam Gandy, Michelle E. Ehrlich

Excerpt

Correction: Journal of Neuroinflammation (2023) 20:214 https://doi.org/10.1186/s12974-023-02895-7 …

Gandy S, Ehrlich ME. miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy. J Neuroinflammation. 2023;20:214. https://doi.org/10.1186/s12974-023-02895-7.CrossRefPubMedPubMedCentral

Title: Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy
Authors: Sam Gandy
Michelle E. Ehrlich
Publication date: 01-12-2023
Publisher: BioMed Central
Published in: Journal of Neuroinflammation / Issue 1/2023
Electronic ISSN: 1742-2094
DOI: https://doi.org/10.1186/s12974-023-02954-z